首页|期刊导航|Genes & Diseases|Intra-tumoral microbiota:Key modulators of tumor immunity and therapeutic potential

Intra-tumoral microbiota:Key modulators of tumor immunity and therapeutic potentialOA

中文摘要

The tumor microenvironment is increasingly recognized as a complex ecosystem in which the intra-tumoral microbiota(comprising bacteria,fungi,viruses,etc.)plays a pivotal,underappreciated role in cancer biology.This review systematically summarizes the latest research into the origins,diversity,and functional mechanisms of intra-tumoral microbiota,emphasizing their dual roles in tumor formation,progression,and response to treatment.Using high-throughput sequencing,spatial multi-omics,and integrative bioinformatics,we identify the multifactorial origins of tumor-resident microbiota,including translocation from adjacent tissues,hematogenous dissemination,and viral genomic integration.We also examine the significant inter-and intra-tumoral microbial heterogeneity influenced by anatomical,environmental,and immunological factors,and the tissue-specific functional effects of important microbial species.We detail the mechanisms by which the intra-tumoral microbiota modulate innate and adaptive immunity through pattern recognition receptor signaling,microbial antigen presentation,and microbial metabolite production,ultimately influencing tumor microenvironment composition,immune cell dynamics,and therapeutic efficacy.Finally,we critically evaluate emerging microbiota-targeted therapeutic strategies,including engineered bacteria,antibiotics,bacteriophages,and oncolytic viruses,while outlining the technical,mechanistic,and regulatory challenges that hinder their clinical translation.Our synthesis highlights the need for rigorous multi-omics profiling,causal inference,and smart delivery systems to exploit the intra-tumoral microbiota for precision oncology.This paradigm shift offers unprecedented opportunities for personalized diagnosis and therapy,marking a new frontier in cancer research and treatment.

Junju He;Hui Tan;Yanru Qiu;Yuchao Dan;Qian Wan;Lan Li;Jie Wu;Qibin Song;Hongbin Chen;Bin Xu

Cancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaDepartment of Radiology,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaOncology Department,Jianli People’s Hospital,Jingzhou,Hubei 433300,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaDepartment of Pulmonary and Critical Care Medicine,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,ChinaCancer Center,Renmin Hospital of Wuhan University,Wuhan,Hubei 430060,China

医药卫生

Cancer therapeuticsIntra-tumoral microbiotaMicrobial heterogeneityTumor immunityTumor microenvironment

《Genes & Diseases》 2026 (4)

P.434-456,23

funded by the National Natural Science Foundation of China(No.82403850,82203502)the Cross Innovation Talent Project of Renmin Hospital of Wuhan University(China)(No.JCRCGW-2022-002)the Natural Science Foundation of Hubei Province,China(No.2021CFB086).

10.1016/j.gendis.2025.101963

评论